Oral or Inhaled Treprostinil in the Treatment of Patients With Pulmonary Arterial Hypertension and Cardiovascular Comorbidities
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Treatment with Oral or Inhaled Treprostinil in Patients with Pulmonary Arterial Hypertension and Cardiovascular Comorbidities
Chest 2024 Nov 30;[EPub Ahead of Print], RJ White, K El-Kersh, S Rosenkranz, V Franco, CD Vizza, R Badagliacca, J Pepke-Zaba, J Elwing, RG Argula, S Shapiro, H Kim, S Seaman, E Shen, M Das, M Broderick, V McLaughlinFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.